Efficacy Response News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Efficacy response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Efficacy Response Today - Breaking & Trending Today

High testosterone levels in older men associated with greater risk of atrial fibrillation

Researchers investigated whether higher endogenous testosterone levels increase atrial fibrillation (AF) risk among healthy older males. ....

Orawan Pattarawimonchai Shutterstock , Testosterone Replacement Therapy , Long Term Vascular Events , Efficacy Response , Hypogonadal Men , Reducing Events , Atrial Fibrillation ,

Testosterone Replacement Therapy Does Not Prevent Diabetes - Renal and Urology News

Men with prediabetes and diabetes have a high prevalence of hypogonadism. A trial tested testosterone replacement therapy’s efficacy in preventing progression from prediabetes to diabetes in men. ....

Ann Arbor , United States , Shalender Bhasin , Kennethe Covinsky , Harvard Medical School , University Of Michigan , Testosterone Replacement Therapy , Long Term Vascular Events , Efficacy Response , Hypogonadal Men , Lona Mody ,

Testosterone Replacement Therapy for Hypogonadism Improves Mood, Energy

Testosterone replacement therapy for hypogonadism was associated with improved mood and energy among participants with depressive symptoms. ....

Patient Health , Clinical Endocrinology , Testosterone Replacement Therapy , Long Term Vascular Events , Efficacy Response , Hypogonadal Men ,

Testosterone Replacement Therapy for Hypogonadism Improves Mood, Energy

Testosterone replacement therapy for hypogonadism was associated with improved mood and energy among participants with depressive symptoms. ....

Patient Health , Clinical Endocrinology , Testosterone Replacement Therapy , Long Term Vascular Events , Efficacy Response , Hypogonadal Men ,

Prostate Risks Similar for Testosterone Therapy and Placebo

For men with hypogonadism and low prostate cancer risk, TRT didn't increase the risk for prostate adverse events, said a new analysis likely to inform decision-making. ....

United States , Shalender Bhasin , Harvard Medical School , Testosterone Replacement Therapy , Long Term Vascular Events , Efficacy Response , Hypogonadal Men , Prostate Carcinoma , Alignant Prostate Neoplasm , Prostate Cancer , Ancer Of The Prostate , Benign Prostatic Hyperplasia , Benign Prostatic Hypertrophy , Ph Benign Prostatic Hyperplasia , Odular Hyperplasia , Ep Benign Enlargement Of The Prostate , Prostate Specific Antigen , Sa Prostate Specific Antigen , Alignant Neoplasia , Alignant Neoplasm ,